Dr. Omar Ali

Can we afford a Cure? Paying for innovation with new medicines · BSc(Hons)Pharm DipClinPharm MRCPharm ACPP Former Government Adviser NICE Head of Payers, Verpora · UK

As Head of Payers at Verpora, Omar works with pharmaceutical and life sciences organisations to shape access strategy, value communication and pricing negotiations across global markets. Drawing on more than 30 years of experience from both government & commercial payer perspective, including a decade at the internationally recognised HTA body NICE, he supports clients in navigating payer expectations and developing practical access strategies. Omar leads Verpora’s global network of more than 150 current and former payers across EU, US, EMEA, APAC and LATAM, supporting both the Access Strategy and Business Insights arms of the business. Over the past 20 years he has supported more than 100 pharmaceutical and life sciences organisations worldwide. He is particularly valued for translating payer expectations into clear, actionable strategies that strengthen value propositions, improve negotiation readiness and support sustainable patient access to medical technologies. Over the last few years, he has worked in partnership with a Washington based Law Firm to prepare, develop and support 7x US pharmaceutical manufacturers across both 1st round & 2nd round of CMS/Medicare Drug Price Negotiations. He hosts the Payer Exchange Podcast (Spotify & Apple Music) and leads Verpora’s IC Fireside Chat (www.verpora.com) video series, exploring real-world access and pricing challenges with payers and industry leaders. He is also a frequent keynote speaker on innovative contracting and value-based agreements at international conferences and senior industry forums, including the American Managed Care Pharmacy Association (US), World Orphan Drug Congress (Barcelona), European Pricing & Access (Amsterdam), Value Based & Innovative Contracting in Oncology (Dubai) and US commercial contracting leadership events such as Rainmaker (Model-N) Austin Texas and PPIC (Eversana/Navlin) Orlando, all in the last 12months! He has been a visiting lecturer on payer value frameworks and innovative contracting methodologies at several universities, including Portsmouth, UCL, Lisbon and Barcelona Business School. His work has appeared in Pharmacy in Practice, Guidelines in Practice and The Canadian Journal of Population Therapeutics and Clinical Pharmacology. He has authored more than 35 publications, including his PhD thesis paper, Establishing the cost of implementing a performance-based managed entry agreement for a hypothetical CAR T-cell therapy. Omar brings a distincti

Speaking at 20th International Healthcare,Hospital Management,Nursing, Patient Safety Conference, 2027-06-23 – 2027-06-24. See all speakers →